Inicio・Lista de Acciones・Novocure Ltd

Novocure Ltd

Cerrado

SectorSanidad

17.79 -10.6

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

17.23

Máximo

21.33

Métricas clave
By Trading Economics
Ingresos	-47M -71M
Ventas	-295K 174M
BPA	-0.62
Margen de beneficios	-40.871
Empleados	1,605
EBITDA	-29M -63M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+27.56% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	401M 1.8B
Apertura anterior	28.39
Cierre anterior	17.79

Noticias sobre sentimiento de mercado

By Acuity

55%

45%

273 / 340 Clasificación en Healthcare

Novocure Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 jul 2026, 19:41 UTC

News

Social Media

Novocure Ltd's stock is lower following its Q2 earnings report, despite a narrower loss and revenue beat. Analysts lowered price targets amid ongoing investor concerns.

22 jul 2026, 20:04 UTC

Shares of Novocure Ltd. are lower today, continuing a decline since Tuesday's close amid broader market uncertainty ahead of the Federal Reserve meeting.

20 jul 2026, 14:36 UTC

Novocure Ltd. is trading higher since Friday's close, despite pulling back from an early session high amid broader market volatility from geopolitical tensions.

Comparación entre iguales

Cambio de precio

Novocure Ltd previsión

Precio Objetivo

By TipRanks

27.56% repunte

Estimación a 12 Meses

Media 25.5 USD 27.56%

Máximo 52 USD

Mínimo 17 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Novocure Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para Novocure Ltd Dist en los últimos 3 meses.

Sentimiento

By Acuity

273 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.